Bizarre Patents
A simulation environment for the sport of boxing utilizing a robotic machine interface system which carries a person.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8188068 | Bridged polycyclic compound based compositions for coating oral surfaces in pets A pharmaceutically active agent, a pharmaceutically active agent carrier and method of use thereof are described. In some embodiments, a system may include a composition. The composition may include one or more bridged polycyclic compounds. At least one of the bridg... | 05/29/2012 |
| 8188067 | Formulations of 6-mercaptopurine The present invention provides improved formulations of 6-mercaptopurine that exhibit better bioavailability and faster dissolution than previous formulations. ... | 05/29/2012 |
| 8178520 | Macrocyclic compounds as antiviral agents The present invention relates to macrocyclic compounds of formula (I): wherein W, n, R1, Ra, Rb, R3, R4, M, Z, ring A and ring B are defined herein, and pharmaceutically acceptable salts thereof, pharmaceutical ... | 05/15/2012 |
| 8173629 | Method of treatment using fatty acid synthesis inhibitors The present invention relates to natural products that possess fatty acid synthesis inhibitor activity and can be used to treat and prevent diseases such as obesity, cancer, diabetes, fungal infections, Mycobacterium tuberculosis infections, malarial infections and ... | 05/08/2012 |
| 8153618 | Bridged polycyclic compound based compositions for topical applications for pets A pharmaceutically active agent, a pharmaceutically active agent carrier and method of use thereof are described. In some embodiments, a system may include a composition. The composition may include one or more bridged polycyclic compounds. At least one of the bridg... | 04/10/2012 |
| 8153617 | Bridged polycyclic compound based compositions for coating oral surfaces in humans A pharmaceutically active agent, a pharmaceutically active agent carrier and method of use thereof are described. In some embodiments, a system may include a composition. The composition may include one or more bridged polycyclic compounds. At least one of the bridg... | 04/10/2012 |
| 8153619 | Diazonamide analogs Novel diazonamide analogs having anti-mitotic activity, useful for the treatment of cancer and other proliferative disorders are provided. ... | 04/10/2012 |
| 8148358 | Blue colour filters with enhanced contrast The invention relates to a process for enhancing the contrast of color filters comprising α copper phthalocyanine or ε copper phthalocyanine, wherein a 1,4-diamino-anthraquinone dye or 1,9-annellated derivative thereof, of which the most bathochromic solution abso... | 04/03/2012 |
| 8148357 | Method for the production of resin particles Resin particles are produced by adding a liquid material having a boiling point of 100° C. or higher to an aqueous dispersion of resin particles to yield a mixture, recovering a wet cake from the mixture by filtration, and drying the wet cake. A water-soluble mater... | 04/03/2012 |
| 8148356 | Acetylcysteine composition and uses therefor This invention relates to novel acetylcysteine compositions in solution, comprising acetylcysteine and which are substantially free of metal chelating agents, such as EDTA. Further, this invention relates to methods of making and using the acetylcysteine composition... | 04/03/2012 |
| 8148359 | Chelating agents of metal ions, their methods of preparation and their applications The present invention relates to compounds that can be used as metal-ion-chelating agents or as depolluting agents, corresponding to general formula (I) below: and also to precursor compounds of formula (II) and labelled co... | 04/03/2012 |
| 8143241 | DNA damage repair inhibitors for treatment of cancer The present invention relates to the recognition that inhibition of the base excision repair pathway is selectively lethal in cells which are deficient in HR dependent DNA DSB repair. Methods and means relating to the treatment of cancers which are deficient in HR d... | 03/27/2012 |
| 8138167 | Methods for treating lung cancers The present invention provided methods for treating lung cancers using therapeutic agents for lung cancers comprising erbB receptor inhibitors as active ingredients. Methods for examining the responsiveness of lung cancer patients to erbB receptor inhibitors by usin... | 03/20/2012 |
| 8129365 | Water-soluble, fluorescent compounds for detection of potassium ions The invention provides chromoionophore compounds comprising a triazacryptand (TAC) K+ ionophore conjugated to at least a first chromophoric moiety (e.g., xanthylium dyes and derivatives thereof). In related embodiments, the chromoionophore compounds furth... | 03/06/2012 |
| 8124599 | Method for treating neuronal and non-neuronal pain A method for the combined treatment of neuronal and non-neuronal pain in mammals is provided comprising administration of adenylyl cyclase 1 inhibitors having the following general formula (1): (1) wherein: G, H, J and M are each N, or H and J are each C, and G and ... | 02/28/2012 |
| 8119609 | Methods of treating diabetic retinopathy with pericyte apoptosis inhibitors A method of preventing or treating diabetic retinopathy is disclosed including administering to a mammal a therapeutically effective amount of an inhibitor of retinal pericyte apoptosis. Also disclosed is a pharmaceutical composition which treats and/or prevents dia... | 02/21/2012 |
| 8114863 | Compounds comprising short aminoalcohol chains and metal complexes for medical imaging The present invention relates to a compound of formula (II) chosen from (IIa) and (IIb) or of formula (VI) chosen from (VIa) and (VIb) of following general formulae: in which: X1, X2, X | 02/14/2012 |
| 8114864 | Macrolide antibiotics and their use for medical purposes The invention provides novel Thuggacin-Type macrolide compounds which form rearrangement products forming a lacton bond to different carbon atoms. The novel compounds can be produced by fermentation of Sorangium cellulosum and Chondromyces crocatus and... | 02/14/2012 |
| 8110565 | Enhanced drug delivery in transdermal systems A composition for transdermal administration resulting from an admixture includes: a therapeutically effective amount of a drug that includes a parent drug and a prodrug; and a pharmaceutically acceptable carrier, wherein the parent drug and prodrug are individually... | 02/07/2012 |
| 8101594 | Method for improving pancreatic functions Compounds such as 4-methylcholest-7-en-3-ol, 4-methylergost-7-en-3-ol and 4-methylstigmast-7-en-3-ol which have an activity for improving pancreatic function are used as an active ingredient of a pancreas function improving drug and food or drink. ... | 01/24/2012 |
| 8101595 | Antiviral indoles Compounds of the formula (I) wherein A, B, D, M, Ar, W, X, Y, Z and R1 are as defined herein, are useful in the prevention and treatment of hepatitis C infections. The compounds, their preparation, pharmaceutical compositions containing them and their use... | 01/24/2012 |
| 8097607 | Low dose rifalazil compositions The invention features low-dosage rifalazil compositions which are useful for the treatment of bacterial infections. ... | 01/17/2012 |
| 8097608 | Methods for treatment of cardiovascular disorders and diseases Propargylamine, propargylamine derivatives including N-propargyl-1-aminoindan, enantiomers and analogs thereof, and pharmaceutically acceptable salts thereof, are useful for prevention or treatment of cardiovascular disorders, diseases and conditions. ... | 01/17/2012 |
| 8093235 | Macrocyclic compounds which stabilize G-Quadruplex DNA and RNA The invention provides compounds of formula I: wherein A, B, D, E, R1, R2, R3, R4, R5, X, and ----- have any values defined herein, as well as salts thereof. The compou... | 01/10/2012 |
| 8093234 | Method of increasing thymic output in HIV-negative patients by treatment with antiretroviral agents A method of increasing thymic output in an HIV-negative patient, comprising the steps of (a) identifying a HIV-negative patient who is in need of increased thymic output and (b) supplying an effective amount of antiretroviral agent to the patient such that the patie... | 01/10/2012 |
| 8088759 | 1,4-benzodiazepine-2,5-diones with therapeutic properties The present invention relates to novel chemical compounds, methods for their discovery, and their therapeutic use. In particular, the present invention provides novel 1,4-benzodiazepine-2,5-dione compounds, and methods of using novel 1,4-benzodiazepine-2,5-dione com... | 01/03/2012 |
| 8084447 | Pharmaceutical composition comprising gabapentin or an analogue thereof and an α-aminoamide and its analgesic use There is disclosed a pharmaceutical composition comprising gabapentin or an analogue thereof (pregabalin or tiagabine) and an α-aminoamide and its analgesic use. A synergistic effect of the respective analgesic activities without concomitant increase of side effect... | 12/27/2011 |
| 8071580 | Medium-chain length fatty alcohols as stimulators of hematopoiesis Medium-chain length fatty alcohols such as octanol, decanol, dodecanol, or analogues thereof can be used as a stimulator of hematopoiesis, hematopoietic stem cell proliferation, and/or proliferation of one or more of the progenitors of red or white blood cells (e.g.... | 12/06/2011 |
| 8071579 | DNA damage repair inhibitors for the treatment of cancer The present invention relates to the recognition that inhibition of the base excision repair pathway is selectively lethal in cells which are deficient in HR dependent DNA DSB repair. Methods and means relating to the treatment of cancers which are deficient in HR d... | 12/06/2011 |
| RE43003 | Epothilone derivatives The present invention relates to compounds of the formula in which the variables G, W, Q, X, Y, B1, B2, Z1, Z2, and R1–R7 are as defined herein, methods fo... | 12/06/2011 |
| 8067402 | Methods and systems for coating an oral surface A coating system and method are described. In some embodiments, a system may include a composition. The composition may include one or more bridged polycyclic compounds. At least one of the bridged polycyclic compounds may include at least two cyclic groups, and at ... | 11/29/2011 |
| 8067403 | Methods and systems for preparing an antimicrobial composition A coating system and method are described. In some embodiments, a system may include a composition. The composition may include one or more bridged polycyclic compounds. At least one of the bridged polycyclic compounds may include at least two cyclic groups, and at ... | 11/29/2011 |
| 8063032 | Histamine H3 inverse agonists and antagonists and methods of use thereof Provided herein are fused imidazolyl compounds, methods of synthesis, and methods of use thereof. The compounds provided herein are useful for the treatment, prevention, and/or management of various disorders, such as neurological disorders and metabolic disorders. ... | 11/22/2011 |
| 8053429 | Solid oral dosage form containing an enhancer The invention relates to a solid oral dosage form comprising a pharmaceutically active ingredient in combination with an enhancer which enhances the bioavailability and/or the absorption of the active ingredient. Accordingly, a solid oral dosage form comprises a dru... | 11/08/2011 |
| 8053428 | Vinorelbine derivatives The present invention relates to novel vinorelbine derivatives. Pharmaceutical compositions containing these compounds as well as processes of preparation and processes of use for treatment of various conditions are also disclosed. ... | 11/08/2011 |
| 8053430 | Treatment of renal cell carcinoma Methods are provided of treating renal cancer by administration of certain 3,3′,4,4′-tetrahydroxy-2,2′-bipyridine-N,N′-dioxide compounds, especially 3,3′,4,4′-tetrahydroxy-2,2′-bipyridine-N,N′-dioxide (Orellanine), using particular administration pro... | 11/08/2011 |
| 8048871 | Compositions and methods for inhibiting cytochrome P450 Methods of inhibiting cytochrome P450 enzymes are provided that can be used for improving the treatment of diseases by preventing degradation of drugs or other molecules by cytochrome P450. Pharmaceutical compositions are provided that can act as boosters to improve... | 11/01/2011 |
| 8048873 | Synergistic pharmaceutical combination for the prevention or treatment of diabetes The invention refers to a synergistic pharmaceutical combination which comprises (a) a first pharmaceutical composition containing an antidiabetic or anti-hyperlipidemic active agent and one or more conventional carrier(s), and (b) a second pharmaceutical compositio... | 11/01/2011 |
| 8048872 | Treatment of hyperproliferative diseases with vinca alkaloid N-oxide and analogs The present invention relates to vinca alkaloid and analog N-oxides having activity for treating hyperproliferative disorders. Further, the invention relates to pharmaceutical compositions and methods of using vinca alkaloid and analog N-oxides, alone or in combinat... | 11/01/2011 |
| 8048870 | Apoptosis-inducing antineoplastic silver (I) coordination complexes The present invention describes chemotherapeutic compositions, a method for making the same, and methods for inducing apoptosis in tumor cells and/or inhibiting tumors. The compositions are metal coordination complexes of a cytotoxic metal, such as silver(I) and a c... | 11/01/2011 |
